Impact of the protein corona on metal oxide nanoparticle-induced toxicity mechanisms
Impact of the protein corona on metal oxide nanoparticle-induced toxicity mechanisms
批准号:
323895699
负责人:
Dr. Dominic Docter
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2019-12-31
中文摘要
除了纳米颗粒在工业产品中的广泛应用外,其生物医学应用也在不断扩大。尽管这两项发展都将导致人类越来越多地接触到纳米颗粒,但我们目前对纳米生物界面过程的机械知识仍然是碎片化的。NPs在与所有生物环境接触时吸附生物分子,形成所谓的np -生物分子电晕。重要的是,我们和其他人表明,特别是蛋白质冠不仅严重影响纳米毒理学,而且还影响纳米生物医学应用的成功和安全。因此,生物系统面对的大多不是原始制造的,而是冠状涂层的转化NPs。此外,冠状蛋白影响纳米生物界面的潜在分子机制尚未解决。我们发现,关注高度可控的NP模型并结合系统分析是将观察到的效应与不同的NP特征相关联的关键。因此,我们将研究金属氧化物NPs (MOx_NPs),它不仅代表了工业和生物医学相关的NPs类别,而且是一个优秀的模型系统。MOx_NPs的物理化学特性。因此,它们与其他金属的受控掺杂可以控制它们的反应性,从而将反应性与生物效应联系起来。然而,蛋白质冠的相关性目前尚未得到研究。基于我们之前的工作,我们预计电晕也是影响氧化应激、(亚毒性)信号传导、细胞摄取和细胞内溶解过程的mox_nps触发(不良)生物效应的关键因素。因此,将可控的MOx_NPs合成和表征与最先进的分析方法相结合,如多参数高含量分析、基于质谱的蛋白质组学以及(共培养)体外暴露细胞模型,该项目的科学目标是:分析生物分子电晕对PdO / fe掺杂MOx_NPs的理化性质(尺寸、表面电荷、胶体稳定性、老化)的影响。目标2。MOx_NPs蛋白冠状体的定量蛋白质组学分析。目标3。采用系统的高含量细胞分析来确定蛋白质冠对人体暴露细胞模型中活性、信号传导和氧化应激反应的影响。目标4。与MOx_NPs纳米结构-活性关系(nanoSARs)相关的蛋白冠特征的生物信息学相关分析和鉴定。目标5。通过分离实验和功能评价实验,鉴定与mox_nps诱导(病理)生物学效应相关的关键冠状蛋白。所产生的知识不仅将提高我们对纳米-生物界面基本过程的理解,而且可以随后用于合理设计具有更高功效、安全性和生物相容性的纳米材料。
英文摘要
Besides the prevalent use of nanoparticles (NPs) in industrial products, also their biomedical applications are expanding. Although both developments will result in an increasing exposure of humans to NPs, our current mechanistic knowledge of processes at the nano-bio interface is still fragmented. NPs adsorb biomolecules upon contact with all biological environments forming the so called NP-biomolecule corona. Importantly, we and others showed that particularly the protein corona critically impacts not only nanotoxicology but also the success and safety of nanobiomedical applications. Thus, biological systems are mostly not facing pristine manufactured but rather corona-coated transformed NPs. Moreover, the underlying molecular mechanisms how corona proteins affect the nano-bio interface are not yet resolved. We showed that focusing on highly controllable NP models combined with systematic analysis is key to correlate observed effects with distinct NP characteristics. Hence, we will investigate metal oxide NPs (MOx_NPs) not only representing an industrially and biomedical relevant category of NPs but also an excellent model system. Indeed the MOx_NPs physico-chemical characteristics. Hence, their controlled doping with other metals allows to control their reactivity and thus, to correlate reactivity with biological effects. However, the relevance of the protein corona was not studied so far. Based on our previous work we expect that the corona is also a key factor for MOx_NPs-triggered (adverse) biological effects by influencing oxidative stress, (subtoxic) signalling, cellular uptake, and intracellular dissolution processes. Consequently, combining controlled MOx_NPs synthesis and characterization with state-of-the-art analytical methods, such as multi-parametric high-content analysis, mass-spectrometry based proteomics together with (co-culture) in vitro exposure cell models, the scientific objectives of the project are: Aim 1. Analysing the impact of the biomolecule corona on the physico-chemical properties (size, surface charge, colloidal stability, aging) of MOx_NPs with incremental PdO-/Fe-dopings. Aim 2. Profiling of the MOx_NPs protein coronas by quantitative proteomics. Aim 3. Employing systematic high-content cell-based analysis to determine the impact of the protein corona on vitality, signaling, and oxidative stress responses in human exposure cell models. Aim 4. Bioinformatic correlation analysis and identification of protein corona signatures correlating with the MOx_NPs nano structure-activity relationships (nanoSARs). Aim 5. Experimentally identify key corona proteins causally involved in MOx_NPs-induced (patho)biological effects by fractionation and functional evaluation experiments. The generated knowledge will not only improve our understanding of basic processes at the nano-bio interface but may subsequent exploited to rationally design nanomaterials with improved efficacy, safety, and biocompatibility.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Nanoparticle decoration impacts airborne fungal pathobiology
纳米颗粒装饰影响空气真菌病理学
DOI:
10.1073/pnas.1804542115
发表时间:
2018
期刊:
Proceedings of the National Academy of Sciences
影响因子:
--
作者:
[Westmeier, Solouk-Saran, Vallet, Siemer, Docter, Hasenberg, Hahlbrock, Reinhardt, Schilling, Becker, Gunzer, Hasenberg, Knauer, Stauber]
通讯作者:
Stauber
DOI:
10.1039/c7nr06573f
发表时间:
2018-01
期刊:
Nanoscale
影响因子:
6.7
作者:
[Dana Westmeier;Gernot Posselt;Angelina Hahlbrock;S. Bartfeld;Cecilia Vallet;C. Abfalter;D. Docter;S. Knauer;S. Wessler;R. Stauber]
通讯作者:
Dana Westmeier;Gernot Posselt;Angelina Hahlbrock;S. Bartfeld;Cecilia Vallet;C. Abfalter;D. Docter;S. Knauer;S. Wessler;R. Stauber
DOI:
10.1002/mabi.201600514
发表时间:
2017-02
期刊:
Macromolecular bioscience
影响因子:
4.6
作者:
[Regina Holm;Benjamin Weber;P. Heller;K. Klinker;Dana Westmeier;D. Docter;R. Stauber;Matthias Barz]
通讯作者:
Regina Holm;Benjamin Weber;P. Heller;K. Klinker;Dana Westmeier;D. Docter;R. Stauber;Matthias Barz
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: